Sporadic cases of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the outer covering of the heart) have been reported in children and adolescents after receiving the Pfizer-BioNTech COVID-19 vaccine, the CDC says. USA.
Recent studies have shown that the rare risk of myocarditis and pericarditis associated with the mRNA vaccine against COVID-19 (Pfizer-BioNTech and Moderna)—mainly in men aged 12 to 39 years—can be greatly reduced by prolonging a little more the interval between the first and the second dose.
In children 5 to 11 years of age, there were 11 confirmed reports of myocarditis for every 8 million doses of Pfizer-BioNTech’s COVID-19 vaccine administered between November and December 2021.
A serious allergic reaction, such as anaphylaxis, can occur after receiving any vaccine, including the COVID-19 vaccine, but is not very common.
If your child has a severe allergic reaction after getting vaccinated against COVID-19, vaccine providers can quickly treat your child and call emergency medical services, if necessary.
Vaccination of children in Mexico
The Undersecretary of Prevention and Health Promotion, Hugo López-Gatell, said that this Thursday, June 16, the registry will be opened so that minors are inoculated with the Pfizer vaccine.
“Now we are going to open the last one, which is girls, boys from 5 to 11 years old,” he reported this Tuesday during the weekly report of the Health Pulse. The undersecretary explained that the Mexican government acquired 8 million vaccines to apply to children.
“The contract has already been signed with the Pfizer company for the Pfizer-BioNTech vaccine, around 8 million doses that will allow us to start this vaccination process,” he announced.
Starting Thursday, parents will be able to register their children on the mivacuna.salud.gob.mx portal. On how the vaccine will be applied to minors, López-Gattel explained that it will be by municipalities.
With information from Lidia Arista